Ontology highlight
ABSTRACT:
SUBMITTER: Jones RN
PROVIDER: S-EPMC4914643 | biostudies-other | 2016 Jul
REPOSITORIES: biostudies-other
Jones Ronald N RN Fedler Kelley A KA Scangarella-Oman Nicole E NE Ross James E JE Flamm Robert K RK
Antimicrobial agents and chemotherapy 20160620 7
Gepotidacin, a novel triazaacenaphthylene antibacterial agent, is the first in a new class of type IIA topoisomerase inhibitors with activity against many biothreat and conventional pathogens, including Neisseria gonorrhoeae To assist ongoing clinical studies of gepotidacin to treat gonorrhea, a multilaboratory quality assurance investigation determined the reference organism (N. gonorrhoeae ATCC 49226) quality control MIC range to be 0.25 to 1 μg/ml (88.8% of gepotidacin MIC results at the 0.5 ...[more]